People with atrial fibrillation tend to have a larger left atrium than those without it, which is a known structural change linked to the condition’s persistence, regardless of inflammation levels around the heart’s arteries.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review could confirm whether left atrial size is a consistent predictor of AF progression and recurrence across diverse populations.
A systematic review and meta-analysis of prospective studies measuring left atrial volume index in adults with paroxysmal or persistent AF, with outcomes of AF progression, ablation failure, or stroke over 5 years.
An RCT could determine whether reducing left atrial size (e.g., via early rhythm control) reduces AF burden more than rate control.
A double-blind RCT of 500 adults aged 60–75 with newly diagnosed paroxysmal AF, randomized to early rhythm control (antiarrhythmic + ablation) vs. rate control, with primary outcome of left atrial volume reduction and AF recurrence at 24 months.
A prospective cohort could determine whether baseline left atrial size predicts progression from paroxysmal to persistent AF over time.
A prospective cohort of 800 adults aged 55–75 with paroxysmal AF, undergoing baseline echocardiography to measure left atrial volume index, followed for 5 years with annual ECG monitoring for AF progression.
A case-control study could compare left atrial size between AF patients and controls matched for age and cardiovascular risk factors.
A case-control study of 300 patients: 150 with persistent AF and 150 without AF, matched for age, sex, BMI, and hypertension, all undergoing standardized echocardiography to measure left atrial volume index.
A cross-sectional study can identify whether left atrial size differs between AF and non-AF patients at a single time point, as demonstrated in this study.
A cross-sectional analysis of 80–100 patients with and without AF, all undergoing standardized echocardiography to measure left atrial volume index, adjusting for age, sex, and blood pressure.